Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Urwat Til Vusqa"'
Autor:
Muath, Abdeen, Urwat Til, Vusqa, Palash, Asawa, Kiley, Felton, Derek, Rinchuse, Cyrus, Khan, Yazan, Samhouri, John, Lister
Publikováno v:
Anti-Cancer Drugs. 33:1167-1170
Venetoclax, a highly selective Bcl-2 inhibitor, is an orally bioavailable drug that has been approved as first-line therapy for chronic lymphocytic leukemia (CLL) in combination with obinutuzumab, as well as monotherapy in the setting of relapsed CLL
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Multiple myeloma (MM) is the second most common hematological malignancy, accounting for 1% of all cancers, with median age of diagnosis between 66–70 years. MM remains incurable despite advances in treatment over time. Lenalidomide is
Publikováno v:
Cureus
Vaccination is now considered the best measure in minimizing the morbidity and mortality from the Covid-19 pandemic. Almost all the vaccines are considered safe except for minor and occasional side effects. Some of the commonly reported complications
Autor:
Urwat Til Vusqa, Palash Asawa, Katherine Miller, Ashish Sethi, Robin Raquel Rodriguez, Andrew Friday, Gene Grant Finley
Publikováno v:
Journal of Clinical Oncology. 40:e21084-e21084
e21084 Background: Lung cancer remains the most commonly diagnosed cancer in the United States, as well as the leading cause of cancer-related mortality. Approximately 84% of all lung cancers are non-small cell lung cancer (NSCLC). Most are diagnosed
Autor:
Palash Asawa, Urwat Til Vusqa, Rahul Karna, Shivani Shah, Ryan Sweeney, Thejus Jayakrishnan, Srividya Srinivasamaharaj, Yazan Samhouri, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 40:e16229-e16229
e16229 Background: Obesity has been associated with decreased survival in patients with pancreatic ductal adenocarcinoma (PDAC). However, exact reasons remain unclear. Reduced response to chemotherapy because of obesity-induced desmoplasia has been p
Autor:
Palash Asawa, Urwat Til Vusqa, Rahul Karna, Abraham Attah Attah, Ryan Sweeney, Shivani Shah, Thejus Jayakrishnan, Srividya Srinivasamaharaj, Yazan Samhouri, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 40:e16246-e16246
e16246 Background: Obesity has been identified as a risk factor for pancreatic cancer. The prevalence of obesity has been on a rise in the last two decades. Obesity is defined by the world health organization (WHO) as body mass index (BMI) > 30.0 kg/
Publikováno v:
Blood. 138:4225-4225
Background It is known that malignant hypertension (mHTN) and thrombotic microangiopathy (TMA) commonly coexist. Deciding which phenomenon preceded the other remains a clinical dilemma, specifically in African American patients. However, making that
Autor:
Urwat Til Vusqa, Prerna Mewawalla, Yazan Samhouri, Anna Koget, John Lister, Cyrus Kahn, Maitreyee Rai, Palash Asawa, Santhosh Sadashiv, Salman Fazal
Publikováno v:
Blood. 138:4816-4816
Introduction Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment paradigm for patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and other hematologic malignancies. However, its use is associa
Autor:
Faiz Anwer, Iqraa Ansar, Muhammad Aslam Khan, Yazan Samhouri, John Lister, Lynna Alnimer, Ali Younas Khan, Muhammad S. Anil, Urwat Til Vusqa, Salman Fazal, Muhammad Yasir Anwar, Taha Sheikh
Publikováno v:
Blood. 136:25-26
Introduction The ability of the neoplastic cells to escape from immune surveillance has been considered as a hallmark of cancer. The upregulation of programmed death-1 (PD-1) and programmed death ligand-1/2 (PDL-1) axis is a major immune escape pathw
Publikováno v:
JPMA. The Journal of the Pakistan Medical Association. 69(10)
To determine the perceptions of patients regarding operation theatre conversation and environment during an awake procedure.The descriptive, cross-sectional study was conducted from February to August 2017 in postoperative wards of Military Hospital,